Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Ilex initiates phase I testing of intoplicine

Feb. 6, 1998

DEHOP enters phase I for NHL

Feb. 6, 1998

Preclinical studies support potential of CP-358774 as cancer treatment

Feb. 4, 1998

Newly identified human natural killer cell-activating factor reported by HGS

Feb. 3, 1998

Pharmacological profile of new alkylating agent from Menarini

Feb. 3, 1998

Structure of new IL-6 inhibitors determined at Kitasato Institute

Feb. 2, 1998

Suramin submitted for FDA approval for cancer indication

Jan. 30, 1998

Phase I/II trial results reported for Neovastat in lung cancer

Jan. 30, 1998

Hybridon antitumor antisense compound enters clinical trials

Jan. 29, 1998

Pacific's cancer immunotherapy proves highly effective in rat metastatic mammary tumor model

Jan. 28, 1998

Popular Stories

Today's news in brief
BioWorld
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
University of Southern California reports new MAPT aggregation inhibitors
BioWorld Science
The University of Southern California has identified (2-oxo-2H-chromen-3-yl) scaffold-based carboxamide analogues acting as potent microtubule-associated protein...